Today: 9 June 2026
IREN stock price jumps nearly 9% as crypto miners rally on AI data-center pivot

IREN stock price jumps nearly 9% as crypto miners rally on AI data-center pivot

New York, Jan 16, 2026, 11:26 EST — Regular session

  • IREN shares jump roughly 9% in late-morning trading; bitcoin dips
  • Crypto mining stocks climbed broadly, with Riot Platforms leading the pack
  • Attention shifts to AI data-center leasing and IREN’s upcoming earnings report in February

IREN Limited shares jumped 8.6% to $56.35 in late-morning trading on Friday, bouncing between $51.94 and $56.73 earlier. Bitcoin fell 1.7% to roughly $94,897, yet some U.S.-listed crypto miners like Riot Platforms, Marathon Digital, and CleanSpark posted gains.

This shift is significant as miners are now being valued more for their data-center power and AI infrastructure capabilities than merely bitcoin prices. Traders have eagerly jumped on stocks that highlight “AI and high-performance computing” capacity, especially appealing to big tech firms facing tight power and space constraints.

Riot, a key player in the sector, announced a data center lease and services agreement with Advanced Micro Devices, covering an initial 25 megawatts of “critical IT load”—a capacity metric for computing equipment. The 10-year contract could bring in around $311 million, with options to extend and expand. AMD’s CIO Hasmukh Ranjan emphasized the need for partners that “can match our pace and scale.” riotplatforms.com

IREN has been aiming to align itself similarly. Last November, Microsoft inked a $9.7 billion, five-year cloud contract with IREN, Reuters reported, which includes access to Nvidia’s cutting-edge chips. The rollout is scheduled in phases through 2026 at IREN’s Childress, Texas campus. Reuters also noted the deal could be canceled if IREN misses delivery deadlines.

H.C. Wainwright’s Mike Colonnese recently made waves with what TipRanks called a double upgrade on IREN, moving his rating straight from Sell to Buy and boosting his price target to $80. Colonnese highlighted “the stage is set for a transformative year,” citing the anticipated AI spending by hyperscalers and IREN’s secured capacity, according to the TipRanks report. TipRanks

Investors have been digging into the company’s filings. On Jan. 2, IREN filed a registration statement to register 17.5 million ordinary shares, earmarked for potential issuance under its 2025 Omnibus Incentive Plan. The company said shareholders gave the green light at the Nov. 19 annual meeting. The filing clarifies that registering the shares “does not constitute a current issuance” of those shares.

Yet the pivot story isn’t without hazards. Data-center expansions hinge on power availability, equipment deliveries, and construction timelines, with contracts often tied to hitting specific milestones. These stocks stay volatile, and bitcoin swings can quickly overshadow the AI-driven momentum.

IREN’s next big event is its upcoming quarterly earnings report. According to TipRanks, the fiscal second-quarter results are expected after the close on Feb. 18. That date could shift, though, as companies often update their schedules.

For now, traders are focused on two key factors: whether the sector’s AI-leasing news continues to drive miners upward, and if IREN provides updates on new AI cloud contracts or progress in deployment.

Stock Market Today

  • Proxy Adviser Supports Nanoco Group's Plan to Delist from LSE
    June 9, 2026, 9:17 AM EDT. Nanoco Group PLC, a nanotechnology firm, announced that independent proxy adviser Glass Lewis has recommended shareholders approve the company's resolution to delist from the London Stock Exchange (LSE). The move signals a significant shift for Nanoco, potentially changing its trading and regulatory environment. Shareholder approval for such a resolution typically permits a company to withdraw its shares from public exchange trading, often to pursue private ownership or alternative funding routes. This development follows Nanoco's strategic review and may impact investor access and share liquidity. The recommendation by Glass Lewis adds weight to the proposal ahead of the upcoming shareholder vote.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Denison Mines stock jumps with uranium names as Phoenix approvals come into focus
Previous Story

Denison Mines stock jumps with uranium names as Phoenix approvals come into focus

Costco stock price dips as dividend lands; investors wait on sales and earnings
Next Story

Costco stock price dips as dividend lands; investors wait on sales and earnings

Go toTop